Astrana Health ASTH Stock options excluded as their inclusion would be anti-dilutive (in shares)

Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies

ValvolineVVV

600K+500%

V2XVVX

74K+469%

Payoneer Global Inc.PAYO

38.4M+44.1%

Albany International Inc.AIN

200K—

Kyndryl HoldingsKD

6.2M+12.7%

PhotronicsPLAB

5K-99.5%

Other financials

Income statement

See full

Revenue$965.1M+55.6%

Gross profit$105.7M+48.2%

Operating income$28.5M+38.6%

Net income$14.4M+116%

EPS (diluted)$0.29+107%

Balance sheet

See full

Cash & equivalents$478.4M+85.0%

Total debt$1.1B+136%

Total equity$800.3M+7.4%

Total assets$2.4B+77.2%

Cash flow

See full

Operating cash flow$68.1M+309%

CapEx$4.0M+30.3%

Free cash flow$64.1M+372%

Valuation

See full

Market cap$2.1B-3.0%

Profitability

See full

Gross margin10.7%-1.3pp

Operating margin2.5%-1.1pp

Net margin0.9%—

FCF margin4.6%—

Returns & leverage

See full

Return on equity3.9%—

Debt / equity1.3×+0.7×

Current ratio1.3×-0.4×

Where this comes from

Reported directly by Astrana Health in its filing.

Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.

The official record: Astrana Health’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Astrana Health's stock options excluded as their inclusion would be anti-dilutive (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Astrana Health's stock options excluded as their inclusion would be anti-dilutive (in shares)?: Astrana Health (ASTH) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 2.4M in Q1 2026.
How has Astrana Health's stock options excluded as their inclusion would be anti-dilutive (in shares) changed year-over-year?: Astrana Health's stock options excluded as their inclusion would be anti-dilutive (in shares) increased by 47.3% year-over-year, from 1.7M to 2.4M.